UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Interleukin-12: Biological Properties and Clinical Application

Clinical cancer research, 2007-08, Vol.13 (16), p.4677-4685

2007

Volltextzugriff (PDF)

Establishment of Humanized Mice from Peripheral Blood Mononuclear Cells or Cord Blood CD34+ Hematopoietic Stem Cells for Immune‐Oncology Studies Evaluating New Therapeutic Agents

Current Protocols in Pharmacology, 2020-06, Vol.89 (1), p.e77-n/a

2020

Volltextzugriff (PDF)

4 3D Coculture platform reveals insights into patient autologous immune cell-tumor interaction and immune modulation in vitro

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A4-A4

2021

Volltextzugriff (PDF)

A novel probe for the non-invasive detection of tumor-associated inflammation

Oncoimmunology, 2013-02, Vol.2 (2), p.e23034-e23034

2013

Volltextzugriff (PDF)

88 Development of a 3D organoid autologous TIL co-culture platform for high throughput immuno-oncology studies

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A56-A56

2020

Volltextzugriff (PDF)

Visualizing arthritic inflammation and therapeutic response by fluorine-19 magnetic resonance imaging (19F MRI)

Journal of inflammation (London, England), 2012-06, Vol.9 (1), p.24-24, Article 24

2012

Volltextzugriff (PDF)

Novel in Vitro and In Vivo Drug Screening Platform for ALL

Blood, 2021-11, Vol.138 (Supplement 1), p.1189-1189

2021

Volltextzugriff (PDF)

Abstract 2990: In vitro drug sensitivity screening platform for primary chronic lymphocytic leukemia (CLL) patient samples

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.2990-2990

2021

Volltextzugriff (PDF)

Establishment of in Vitro Drug Sensitivity Screening Assay for Chronic Lymphocytic Leukemia (CLL) Primary Patient Samples

Blood, 2020-11, Vol.136 (Supplement 1), p.42-42

2020

Volltextzugriff (PDF)

Establishment ofin VitroDrug Sensitivity Screening Assay for Chronic Lymphocytic Leukemia (CLL) Primary Patient Samples

Blood, 2020-11, Vol.136, p.42-42

2020

Volltextzugriff (PDF)

Circulating Type-1 Anti-Tumor CD4(+) T Cells are Preferentially Pro-Apoptotic in Cancer Patients

Frontiers in oncology, 2014-01, Vol.4, p.266-266

2014

Volltextzugriff (PDF)

Heat Shock Protein 90 Inhibitor 17-Dimethylaminoethylamino-17-Demethoxygeldanamycin Enhances EphA2+ Tumor Cell Recognition by Specific CD8+ T Cells

Cancer research (Chicago, Ill.), 2009-09, Vol.69 (17), p.6995-7003

2009

Volltextzugriff (PDF)

F MRI tracer preserves in vitro and in vivo properties of hematopoietic stem cells

Cell transplantation, 2013, Vol.22 (1), p.87-97

2013

Volltextzugriff (PDF)

IL-1β induces dendritic cells to produce IL-12

International immunology, 2001-08, Vol.13 (8), p.1053-1061

2001

Volltextzugriff (PDF)

Intralesional delivery of dendritic cells engineered to express T-bet promotes protective type 1 immunity and the normalization of the tumor microenvironment

The Journal of immunology (1950), 2010-09, Vol.185 (5), p.2895-2902

2010

Volltextzugriff (PDF)

Abstract 2978: Unique 3D organoids autologous TIL coculture platform enables high throughput immune-oncology drug response studies

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.2978-2978

2021

Volltextzugriff (PDF)

Abstract 3003: In vitro and in vivo model for evaluation of novel therapeutic agents in patient -derived acute B-lymphoblastic leukemia (B-ALL)

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.3003-3003

2021

Volltextzugriff (PDF)

Effect of Renal Cell Carcinomas on the Development of Type 1 T-Cell Responses

Clinical cancer research, 2004-09, Vol.10 (18), p.6360S-6366s

2004

Volltextzugriff (PDF)

DC expressing transgene Foxp3 are regulatory APC

European journal of immunology, 2010-02, Vol.40 (2), p.480-493

2010

Volltextzugriff (PDF)

Abstract 5046: Natural Killer (NK) human immune system (HIS) immunograft platform to evaluate the pharmacodynamics of immuno-oncology therapeutics

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.5046-5046

2020

Volltextzugriff (PDF)

Abstract 6298: 2D ex vivo patient derived acute myeloid leukemia platform for evaluation of novel molecular targeted therapeutic agents

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.6298-6298

2020

Volltextzugriff (PDF)

Ectopic T-bet Expression Licenses Dendritic Cells for IL-12-Independent Priming of Type 1 T Cells In Vitro

The Journal of immunology (1950), 2009-12, Vol.183 (11), p.7250-7258

2009

Volltextzugriff (PDF)

4-1BB-ligand is regulated on human dendritic cells and induces the production of IL-12

Cellular immunology, 2003-11, Vol.226 (1), p.37-44

2003

Volltextzugriff (PDF)

Increased production of pro-inflammatory cytokines and enhanced T cell responses after activation of human dendritic cells with IL-1 and CD40 ligand

BMC immunology, 2002-10, Vol.3 (1), p.14-14, Article 14

2002

Volltextzugriff (PDF)

Interferon-alpha (IFN-alpha)-conditioned DC preferentially stimulate type-1 and limit Treg-type in vitro T-cell responses from RCC patients

Journal of immunotherapy, 2008-04, Vol.31 (3), p.254-262

2008

Volltextzugriff (PDF)

1 – 25 von 66

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(62)
Mit Volltextzugriff
(56)

Publikationsform

Sprache

Englisch
(66)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(22)
Science & Technology
(22)
Humans
(20)
Immunology
(14)
Dendritic Cells - Immunology
(11)
Oncology
(11)
Animals
(9)
Antineoplastic Agents
(8)
Biological And Medical Sciences
(8)
Immunotherapy
(8)
Medical Sciences
(8)
Pharmacology. Drug Treatments
(8)
Dendritic Cells
(7)
Cd8-Positive T-Lymphocytes - Immunology
(6)
Cells, Cultured
(6)
Tumors
(6)
Cell Line, Tumor
(5)
Cytokines - Immunology
(5)
Dendritic Cells - Cytology
(5)
Female
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Interleukin-12: Biological Properties and Clinical Application

Establishment of Humanized Mice from Peripheral Blood Mononuclear Cells or Cord Blood CD34+ Hematopoietic Stem Cells for Immune‐Oncology Studies Evaluating New Therapeutic Agents

4 3D Coculture platform reveals insights into patient autologous immune cell-tumor interaction and immune modulation in vitro

A novel probe for the non-invasive detection of tumor-associated inflammation

88 Development of a 3D organoid autologous TIL co-culture platform for high throughput immuno-oncology studies

Visualizing arthritic inflammation and therapeutic response by fluorine-19 magnetic resonance imaging (19F MRI)

Novel in Vitro and In Vivo Drug Screening Platform for ALL

Abstract 2990: In vitro drug sensitivity screening platform for primary chronic lymphocytic leukemia (CLL) patient samples

Establishment of in Vitro Drug Sensitivity Screening Assay for Chronic Lymphocytic Leukemia (CLL) Primary Patient Samples

Establishment ofin VitroDrug Sensitivity Screening Assay for Chronic Lymphocytic Leukemia (CLL) Primary Patient Samples

Circulating Type-1 Anti-Tumor CD4(+) T Cells are Preferentially Pro-Apoptotic in Cancer Patients

Heat Shock Protein 90 Inhibitor 17-Dimethylaminoethylamino-17-Demethoxygeldanamycin Enhances EphA2+ Tumor Cell Recognition by Specific CD8+ T Cells

F MRI tracer preserves in vitro and in vivo properties of hematopoietic stem cells

IL-1β induces dendritic cells to produce IL-12

Intralesional delivery of dendritic cells engineered to express T-bet promotes protective type 1 immunity and the normalization of the tumor microenvironment

Abstract 2978: Unique 3D organoids autologous TIL coculture platform enables high throughput immune-oncology drug response studies

Abstract 3003: In vitro and in vivo model for evaluation of novel therapeutic agents in patient -derived acute B-lymphoblastic leukemia (B-ALL)

Effect of Renal Cell Carcinomas on the Development of Type 1 T-Cell Responses

DC expressing transgene Foxp3 are regulatory APC

Abstract 5046: Natural Killer (NK) human immune system (HIS) immunograft platform to evaluate the pharmacodynamics of immuno-oncology therapeutics

Abstract 6298: 2D ex vivo patient derived acute myeloid leukemia platform for evaluation of novel molecular targeted therapeutic agents

Ectopic T-bet Expression Licenses Dendritic Cells for IL-12-Independent Priming of Type 1 T Cells In Vitro

4-1BB-ligand is regulated on human dendritic cells and induces the production of IL-12

Increased production of pro-inflammatory cytokines and enhanced T cell responses after activation of human dendritic cells with IL-1 and CD40 ligand

Interferon-alpha (IFN-alpha)-conditioned DC preferentially stimulate type-1 and limit Treg-type in vitro T-cell responses from RCC patients

Suchergebnisse filtern